PTP Accounts Production v24.1.4.33 05175852 Board of Directors 1.2.23 31.1.24 31.1.24 false true false false true false Ordinary Shares of £1 each 1,505.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh051758522023-01-31051758522024-01-31051758522023-02-012024-01-31051758522021-07-31051758522021-08-012023-01-31051758522023-01-3105175852ns15:EnglandWales2023-02-012024-01-3105175852ns14:PoundSterling2023-02-012024-01-3105175852ns10:Director12023-02-012024-01-3105175852ns10:PrivateLimitedCompanyLtd2023-02-012024-01-3105175852ns10:SmallEntities2023-02-012024-01-3105175852ns10:AuditExempt-NoAccountantsReport2023-02-012024-01-3105175852ns10:SmallCompaniesRegimeForDirectorsReport2023-02-012024-01-3105175852ns10:SmallCompaniesRegimeForAccounts2023-02-012024-01-3105175852ns10:FullAccounts2023-02-012024-01-3105175852ns10:OrdinaryShareClass12023-02-012024-01-3105175852ns10:Director32023-02-012024-01-3105175852ns10:Director42023-02-012024-01-3105175852ns10:Director52023-02-012024-01-3105175852ns10:RegisteredOffice2023-02-012024-01-3105175852ns5:CurrentFinancialInstruments2024-01-3105175852ns5:CurrentFinancialInstruments2023-01-3105175852ns5:ShareCapital2024-01-3105175852ns5:ShareCapital2023-01-3105175852ns5:SharePremium2024-01-3105175852ns5:SharePremium2023-01-3105175852ns5:RetainedEarningsAccumulatedLosses2024-01-3105175852ns5:RetainedEarningsAccumulatedLosses2023-01-3105175852ns5:PlantMachinery2023-01-3105175852ns5:ComputerEquipment2023-01-3105175852ns5:PlantMachinery2023-02-012024-01-3105175852ns5:ComputerEquipment2023-02-012024-01-3105175852ns5:PlantMachinery2024-01-3105175852ns5:ComputerEquipment2024-01-3105175852ns5:PlantMachinery2023-01-3105175852ns5:ComputerEquipment2023-01-3105175852ns10:OrdinaryShareClass12024-01-31
REGISTERED NUMBER: 05175852 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 January 2024

for

BIOEOS Limited

BIOEOS Limited (Registered number: 05175852)






Contents of the Financial Statements
for the Year Ended 31 January 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


BIOEOS Limited

Company Information
for the Year Ended 31 January 2024







DIRECTORS: Dr O A Bottasso
Mrs C A Stanford
Mrs N S Norman
Professor A G Dalgleish





REGISTERED OFFICE: c/o Steinfeld Law LLP
22 Manchester Square
London
W1U 3PT





REGISTERED NUMBER: 05175852 (England and Wales)





ACCOUNTANTS: M N Jenks & Co Limited
72 Commercial Road
Paddock Wood
Tonbridge
Kent
TN12 6DP

BIOEOS Limited (Registered number: 05175852)

Balance Sheet
31 January 2024

31.1.24 31.1.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 15 43

CURRENT ASSETS
Cash at bank 6,484 2,568

CREDITORS
Amounts falling due within one year 5 5,990 1,800
NET CURRENT ASSETS 494 768
TOTAL ASSETS LESS CURRENT
LIABILITIES

509

811

CAPITAL AND RESERVES
Called up share capital 6 1,505 1,505
Share premium 111,511 111,511
Retained earnings (112,507 ) (112,205 )
SHAREHOLDERS' FUNDS 509 811

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 28 October 2024 and were signed on its behalf by:





Mrs C A Stanford - Director


BIOEOS Limited (Registered number: 05175852)

Notes to the Financial Statements
for the Year Ended 31 January 2024

1. STATUTORY INFORMATION

BIOEOS Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents the value of services carried out, excluding VAT, up to the balance sheet date. Turnover relating to the value of services carried out and goods sold is recognised when substantively all the risks and rewards in connection with the goods have been passed to the buyer. This is usually when the goods are delivered.

Tangible fixed assets
Tangible fixed assets are stated at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and Machinery - 20% on straight line basis
Computer Equipment - 33.33% on straight line basis

Taxation
Taxation represents the sum of tax currently payable and deferred tax. Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws.

Debtors and creditors receivable/payable within one year
Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in administrative expenses.

Research and development
Expenditure on research and development is written off in the period in which it is incurred.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 3 ) .

BIOEOS Limited (Registered number: 05175852)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024

4. TANGIBLE FIXED ASSETS
Plant and Computer
machinery equipment Totals
£    £    £   
COST
At 1 February 2023
and 31 January 2024 392 100 492
DEPRECIATION
At 1 February 2023 349 100 449
Charge for year 28 - 28
At 31 January 2024 377 100 477
NET BOOK VALUE
At 31 January 2024 15 - 15
At 31 January 2023 43 - 43

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.24 31.1.23
£    £   
Trade creditors 2,000 -
Other creditors 3,990 1,800
5,990 1,800

6. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.1.24 31.1.23
value: £    £   
1,505 Ordinary Shares of £1 each 1505 1,505 1,505

7. RELATED PARTY TRANSACTIONS

Related Party Relationship Details Amount (£)

Year ended 31 January 2024
Dr O Bottasso Director Consultancy fees paid -
Mrs C A Stanford Director Rent payable 750

Period ended 31 January 2023
Dr O Bottasso Director Consultancy fees paid 4,500
G McIntyre Director Consultancy fees paid 5,525
P Ripley Director Consultancy fees paid 5,500
P J Shelley Director Consultancy fees paid 8,500
Mrs C A Stanford Director Rent paid 5,500